Clinical trial NCT00504244 - References

Systemic Lupus Erythematosus — Myfortic Versus Azathioprine in Systemic Lupus Erythematosus

Citation(s)

•   Abu-Shakra M, Lee P
  Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol. 1995 Nov;22(11):2100-2.
•   Allison AC, Eugui EM
  Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation. 2005 Oct 15;80(2 Suppl):S181-90. Review.
•   Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH
  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 Jun;35(6):630-40.
•   Boumpas DT, Austin HA 3rd, Fessler BJ, Balow JE, Klippel JH, Lockshin MD
  Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med. 1995 Jun 15;122(12):940-50. Review.
•   Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group
  Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005 Apr;16(4):1076-84. Epub 2005 Feb 23.
•   Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D
  Sequential therapies for proliferative lupus nephritis. N Engl J Med. 2004 Mar 4;350(10):971-80.
•   Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A
  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 Jul;86(7):447-58.
•   Mills JA
  Systemic lupus erythematosus. N Engl J Med. 1994 Jun 30;330(26):1871-9. Review.
•   Pisoni CN, Karim Y, Cuadrado MJ
  Mycophenolate mofetil and systemic lupus erythematosus: an overview. Lupus. 2005;14 Suppl 1:s9-11. Review.
•   Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA
  Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol. 1997 Feb;24(2):309-13.

A Randomized, Multicenter Study to Assess the Efficacy on Diseases Activity of Enteric-coated Mycophenolate Sodium Versus Continuation of Azathioprine in Patients With Systemic Lupus Erythematosus on Azathioprine Maintenance Therapy.

Details for clinical trial NCT00504244